{
  "@context": "aku-v2",
  "@type": "concept",
  "@id": "wsmg:health-sciences:medicine:surgery:vascular:pathology:renal-artery:ras-010",
  "metadata": {
    "version": "2.1.0",
    "created": "2026-01-08T21:25:00.000Z",
    "modified": "2026-01-08T21:25:00.000Z",
    "contributors": ["copilot-agent", "vascular-surgery-sme"],
    "confidence": 0.93,
    "status": "pending-quality-check",
    "language": "en",
    "licenses": ["CC-BY-4.0"]
  },
  "classification": {
    "domain_path": "health-sciences/medicine/surgery/vascular/pathology/renal-artery",
    "subdomain": "atherosclerotic-ras",
    "type": "definition",
    "difficulty": "advanced",
    "importance": "critical",
    "isNativeDomain": true,
    "board_yield": "HIGH"
  },
  "content": {
    "title": "Atherosclerotic Renal Artery Stenosis",
    "summary": "Atherosclerotic renal artery stenosis (ARAS) is the most common cause of renovascular hypertension and ischemic nephropathy. While revascularization was once common, current evidence supports medical therapy for most patients with interventions reserved for specific clinical scenarios.",
    "definition": "Narrowing of the renal artery lumen by atherosclerotic plaque, typically involving the ostium and proximal segment, potentially causing renovascular hypertension and/or ischemic nephropathy",
    "epidemiology": {
      "prevalence": {
        "general_hypertension": "1-5% of hypertensive patients",
        "resistant_hypertension": "Up to 20% with resistant hypertension",
        "CKD": "15-20% of patients starting dialysis"
      },
      "demographics": {
        "age": "Typically >55 years",
        "sex": "Male predominance",
        "associations": "Strongly associated with widespread atherosclerosis"
      }
    },
    "pathophysiology": {
      "acute_phase": {
        "mechanism": "Reduced renal perfusion activates RAAS",
        "response": "Renin release → angiotensin II → aldosterone",
        "result": "Sodium retention, vasoconstriction, hypertension"
      },
      "chronic_phase": {
        "renal_adaptation": "Loss of renin-dependence, volume expansion predominates",
        "ischemic_nephropathy": "Progressive parenchymal damage from chronic hypoperfusion",
        "glomerulosclerosis": "Secondary changes from hypertension and hypoperfusion"
      },
      "hemodynamic_significance": "Generally >60-70% stenosis is hemodynamically significant"
    },
    "clinical_presentations": {
      "renovascular_hypertension": {
        "features": [
          "Resistant hypertension (≥3 drugs including diuretic)",
          "Severe hypertension in older patient",
          "Flash pulmonary edema with bilateral disease"
        ]
      },
      "ischemic_nephropathy": {
        "features": [
          "Progressive CKD with renovascular disease",
          "Azotemia with ACE inhibitor initiation",
          "Unexplained CKD with vascular risk factors"
        ]
      },
      "flash_pulmonary_edema": {
        "mechanism": "Bilateral RAS leads to volume overload",
        "significance": "One of few indications with clear revascularization benefit"
      }
    },
    "diagnosis": {
      "clinical_clues": [
        "Resistant hypertension",
        "Creatinine rise with ACEi/ARB",
        "Abdominal bruit",
        "Asymmetric kidney size",
        "Flash pulmonary edema"
      ],
      "imaging": {
        "duplex_ultrasound": {
          "role": "Initial screening",
          "criteria": "Peak systolic velocity >200 cm/s, RAR >3.5",
          "limitations": "Operator dependent, body habitus, technical failure"
        },
        "CTA": {
          "advantages": "High accuracy, assess aorta and branches",
          "limitations": "Contrast load in CKD"
        },
        "MRA": {
          "advantages": "No iodinated contrast, good sensitivity",
          "limitations": "May overestimate stenosis, gadolinium in severe CKD"
        },
        "catheter_angiography": {
          "role": "Gold standard, usually with planned intervention"
        }
      },
      "functional_assessment": {
        "fractional_flow_reserve": "Pressure gradient measurement",
        "captopril_renography": "Historical, less used currently"
      }
    },
    "treatment": {
      "medical_therapy": {
        "first_line": "ACE inhibitors or ARBs (most patients)",
        "monitoring": "Check creatinine 1-2 weeks after initiation",
        "additional": [
          "Statin therapy",
          "Antiplatelet therapy",
          "Blood pressure control (<130/80)"
        ]
      },
      "revascularization_indications": {
        "current_consensus": "Most patients managed medically based on ASTRAL, CORAL trials",
        "potential_indications": [
          "Flash pulmonary edema (strongest indication)",
          "Refractory heart failure with bilateral disease",
          "Rapidly declining renal function attributable to RAS",
          "Truly refractory hypertension despite optimal medical therapy"
        ],
        "options": {
          "stenting": "First-line intervention if indicated",
          "bypass": "Rarely needed; complex anatomy, failed stent, aortic surgery"
        }
      },
      "trial_evidence": {
        "ASTRAL": "No benefit of revascularization over medical therapy for renal function or BP",
        "CORAL": "No benefit for cardiovascular/renal events; criticized for patient selection"
      }
    },
    "prognosis": {
      "progression": "~5% annual progression to total occlusion",
      "mortality": "High cardiovascular mortality (comorbid atherosclerosis)",
      "after_stenting": "Variable; depends on residual renal parenchymal function"
    }
  },
  "skos": {
    "prefLabel": {"@language": "en", "@value": "Atherosclerotic Renal Artery Stenosis"},
    "altLabel": [
      {"@language": "en", "@value": "ARAS"},
      {"@language": "en", "@value": "Renovascular hypertension"},
      {"@language": "en", "@value": "Ischemic nephropathy"}
    ],
    "definition": {"@language": "en", "@value": "Atherosclerotic narrowing of the renal artery causing renovascular hypertension and/or ischemic nephropathy"},
    "notation": "ras-010"
  },
  "relationships": {
    "skos:broader": [{"@id": "wsmg:health-sciences:medicine:surgery:vascular:pathology:renal-artery", "skos:prefLabel": "Renal Artery Disease"}],
    "skos:related": [
      {"@id": "wsmg:health-sciences:medicine:surgery:vascular:pathology:genetic-connective-tissue:fmd-renal", "skos:prefLabel": "Renal FMD"},
      {"@id": "wsmg:health-sciences:medicine:nephrology:ckd", "skos:prefLabel": "Chronic Kidney Disease"}
    ]
  },
  "medicalCode": [
    {
      "@type": "MedicalCode",
      "codingSystem": "ICD-10-CM",
      "codeValue": "I70.1",
      "description": "Atherosclerosis of renal artery"
    },
    {
      "@type": "MedicalCode",
      "codingSystem": "SNOMED-CT",
      "codeValue": "236496002",
      "uri": "http://snomed.info/id/236496002",
      "description": "Atherosclerotic renal artery stenosis"
    }
  ],
  "pedagogical": {
    "learning_objectives": [
      "Describe the pathophysiology of renovascular hypertension",
      "List clinical clues suggesting atherosclerotic RAS",
      "Compare diagnostic imaging modalities",
      "Outline current evidence-based treatment recommendations",
      "Identify indications for revascularization vs medical therapy"
    ],
    "clinical_pearls": [
      "ASTRAL/CORAL: medical therapy equivalent to stenting for most patients",
      "Flash pulmonary edema with bilateral RAS = strongest revascularization indication",
      "Creatinine rise >30% on ACEi/ARB suggests hemodynamically significant RAS",
      "PSV >200 cm/s or RAR >3.5 on duplex suggests significant stenosis",
      "Most RAS is atherosclerotic and ostial; FMD is mid-vessel"
    ],
    "estimated_time": "30min",
    "target_audience": ["vascular_surgery_residents", "nephrology", "cardiology", "interventional_radiology"]
  }
}
